Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

REGISTER for free or LOG IN to view this content

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Heart Failure

THT 2023

THT2023

Up Next

Presentation THT 2023

Afterload pressure and LV function, but not circuit flow or direction, determine left atrial pressure during VA-ECMO

Presenter: Pankaj Jain

March 21, 2023

Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: the VITAL-HF Pilot

Presenter: Marc Samsky

March 21, 2023

Presentation THT 2023

Application of the Cardiogenic Shock Working Group (CSWG)-defined Society for Cardiovascular Angiography and Interventions (SCAI) staging of cardiogenic shock (CS) to the Medical Information Mart for Intensive Care (MIMIC)-IV Database

Presenter: Kevin John

March 21, 2023

Advertisement

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

REGISTER for free or LOG IN to view this content

Up Next

Afterload pressure and LV function, but not circuit flow or direction, determine left atrial pressure during VA-ECMO

Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: the VITAL-HF Pilot

Application of the Cardiogenic Shock Working Group (CSWG)-defined Society for Cardiovascular Angiography and Interventions (SCAI) staging of cardiogenic shock (CS) to the Medical Information Mart for Intensive Care (MIMIC)-IV Database

Advertisement

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

REGISTER for free or LOG IN to view this content

Up Next

We Recommend

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?